Squeeze Report — June 17, 2026
Today's squeeze board is dominated by earnings catalysts clustering in early August, but the most combustible setups are in names where price action has already inflicted pain on shorts — NEO, RHI, and FRMM all show 20-day surges exceeding 23% against double-digit days-to-cover. The real tension sits between cooling borrow costs and still-elevated short interest, making the next earnings prints binary events for covering cascades.
Today's top short-squeeze candidates
- #1NEONeoGenomics, Inc. Common Stock81
A 35.9% short float and 25% rally in 20 days have shorts trapped ahead of August 4 earnings, though collapsing options IV suggests the squeeze may already be leaking.
SI 36%DTC 6.9$10.49+25% 20dHealthcare - #2NTLAIntellia Therapeutics, Inc. Co80
The June 15 Phase 3 data surge may have squeezed some of the 45.7% short float, but a 9.3% float expansion from the April offering dilutes the setup.
SI 46%DTC 9.2$14.55+15% 20dHealthcare - #3MBCMasterBrand, Inc.80
28% of float sold short · 6.7 days to cover · +26% over 20 days
SI 28%DTC 6.7$8.86+26% 20dConsumer Cyclical - #4GPGIGPGI, Inc.79
A 35.6% short float and 15.8 days to cover are overshadowed by a detailed fraud short report and CEO/CFO departures.
SI 36%DTC 15.8$14.02+16% 20dIndustrials - #5BEAMBeam Therapeutics Inc. Common79
BEAM-302's pivotal start could force covering of an 11.7-day short pile, but borrow at 0.25% means no one is being forced out yet.
SI 23%DTC 11.7$30.99+16% 20dHealthcare - #6ABSIAbsci Corporation Common Stock78
A 41% surge and heavy insider buying meet the reality of no efficacy data until late 2026 and active ATM dilution.
SI 24%DTC 7.5$7.00+41% 20dHealthcare - #7ORKAOruka Therapeutics, Inc. Commo78
A 24% short float and 16% rally face the headwind of a $700M April offering now underwater and heavy insider selling.
SI 24%DTC 5.0$67.71+16% 20dHealthcare - #8LQDALiquidia Corporation Common St78
16% of float sold short · 7.8 days to cover · +19% over 20 days
SI 16%DTC 7.8$68.01+19% 20dHealthcare - #9PARPAR Technology Corp.78
A 33.8% short float and 35 insider buys face a 47% dilution overhang from convertibles and McDonald's conspicuous omission from AI initiatives.
SI 34%DTC 9.2$15.49+11% 20dTechnology - #10CNXCConcentrix Corporation Common77
June 29 earnings are a beat-and-raise-or-bust moment for a 21.9% short float, with $4.75B in debt and deteriorating margins as the bear's anchor.
SI 22%DTC 9.0$26.62+11% 20dTechnology - #11RLAYRelay Therapeutics, Inc. Commo76
Zovegalisib's breakthrough designation and a 19% short-interest spike make June 18 OPEX a gamma event, though Roche's Phase 3 readout looms.
SI 25%DTC 5.7$15.05+24% 20dHealthcare - #12TMDXTransMedics Group, Inc. Common76
22% of float sold short · 5.3 days to cover · +11% over 20 days
SI 22%DTC 5.3$75.82+11% 20dHealthcare - #13AIC3.ai, Inc.76
A 37.7% short interest and 25% rally are fighting a 46% revenue collapse and heavy stock-based compensation dilution.
SI 38%DTC 8.7$10.93+25% 20dTechnology - #14PRCHPorch Group, Inc. Common Stock75
18% of float sold short · 9.8 days to cover · +14% over 20 days
SI 18%DTC 9.8$11.40+14% 20dTechnology - #15RHIRobert Half Inc.75
12.8 days to cover and a 23.5% surge set the table for a July 22 earnings showdown, but cheap borrow at 0.42% removes the hard-to-borrow panic.
SI 27%DTC 12.8$32.34+24% 20dIndustrials
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →